#JITC Research: Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer https://t.co/61tc3PV6GE https://t.co/9HzVtwtV6h
8,103 followers
19,274 followers
RT @jitcancer: New #JITC Research: Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young…
8,103 followers
New #JITC Research: Population pharmacokinetics, exposure-safety, and immunogenicity of atezolizumab in pediatric and young adult patients with cancer https://t.co/61tc3PV6GE @ColbyShemesh https://t.co/CFWiNszcvR
8,103 followers
RT @ColbyShemesh: Good job by the team 👍 for providing valuable insight 🔬on atezolizumab in the iMATRIX pediatric trial, much more work 🧰 i…